FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W132034112> ?p ?o ?g. }

• W132034112 abstract "We determined whether statin use was associated with lower all-cause and cardiovascular disease (CVD) mortality in persons with lower extremity peripheral arterial disease (PAD). We also determined whether favorable associations of statin use with mortality were stronger in persons with higher C-reactive protein (CRP) compared to those with lower CRP levels. Participants were 681 men and women with PAD from the Walking and Leg Circulation Study (WALCS) and WALCS II prospective cohort studies. Participants were identified from non-invasive vascular laboratories in Chicago. Participants attended a baseline visit and annual visits for a mean follow-up of 3.7 years. Statin use was determined at baseline and each annual visit. Outcome measures were all-cause and CVD mortality. Time dependent Cox regression analyses were used to evaluate associations of statin use and mortality. Analyses were also repeated separately in participants with baseline CRP values above vs. below the median for the cohort. Analyses were adjusted for age, sex, race, comorbid conditions, ankle brachial index, total cholesterol, high density lipoprotein cholesterol, and other confounders. One hundred fifty five (23%) persons died during follow-up. Two hundred ninety (43%) persons were on a statin at baseline. At baseline, median CRP level was 2.6 mg/L. Statin use was associated with significantly lower all-cause mortality (hazard ratio, 0.52 [95% CI, 0.31 to 0.88], P = 0.014) and CVD mortality (hazard ratio, 0.41 [95% CI, 0.17 to 0.99], P = 0.048) as compared to statin non-use. In persons with CRP >2.6 mg/L, statin use was associated with a significantly lower risk of all-cause mortality (hazard ratio, 0.44 [95% CI, 0.23 to 0.88], P = 0.019, interaction term P = 0.67) and CVD mortality (hazard ratio, 0.20 [95% CI, 0.06 to 0.65], P = 0.0075, interaction term P = 0.39). However, in persons with CRP < 2.6 mg/L, statin use was not associated with lower mortality. Among persons with PAD, statin use is associated with significantly lower all-cause and CVD mortality at mean follow-up of 3.7 years. This finding is largely attributable to favorable associations of statin use with lower mortality among PAD patients with elevated baseline CRP levels." @default.
• W132034112 created "2016-06-24" @default.
• W132034112 creator A5016639693 @default.
• W132034112 creator A5064977813 @default.
• W132034112 creator A5080676116 @default.
• W132034112 creator A5082607003 @default.
• W132034112 date "2008-10-28" @default.
• W132034112 modified "2023-09-25" @default.
• W132034112 title "Abstract 4531: Statin Use Is Associated with Decreased Mortality in Persons with Peripheral Arterial Disease" @default.
• W132034112 doi "https://doi.org/10.1161/circ.118.suppl_18.s_905-b" @default.
• W132034112 hasPublicationYear "2008" @default.
• W132034112 type Work @default.
• W132034112 sameAs 132034112 @default.
• W132034112 citedByCount "0" @default.
• W132034112 crossrefType "journal-article" @default.
• W132034112 hasAuthorship W132034112A5016639693 @default.
• W132034112 hasAuthorship W132034112A5064977813 @default.
• W132034112 hasAuthorship W132034112A5080676116 @default.
• W132034112 hasAuthorship W132034112A5082607003 @default.
• W132034112 hasConcept C126322002 @default.
• W132034112 hasConcept C188816634 @default.
• W132034112 hasConcept C201903717 @default.
• W132034112 hasConcept C207103383 @default.
• W132034112 hasConcept C2776839432 @default.
• W132034112 hasConcept C44249647 @default.
• W132034112 hasConcept C50382708 @default.
• W132034112 hasConcept C71924100 @default.
• W132034112 hasConcept C72563966 @default.
• W132034112 hasConcept C77350462 @default.
• W132034112 hasConceptScore W132034112C126322002 @default.
• W132034112 hasConceptScore W132034112C188816634 @default.
• W132034112 hasConceptScore W132034112C201903717 @default.
• W132034112 hasConceptScore W132034112C207103383 @default.
• W132034112 hasConceptScore W132034112C2776839432 @default.
• W132034112 hasConceptScore W132034112C44249647 @default.
• W132034112 hasConceptScore W132034112C50382708 @default.
• W132034112 hasConceptScore W132034112C71924100 @default.
• W132034112 hasConceptScore W132034112C72563966 @default.
• W132034112 hasConceptScore W132034112C77350462 @default.
• W132034112 hasIssue "suppl_18" @default.
• W132034112 hasLocation W1320341121 @default.
• W132034112 hasOpenAccess W132034112 @default.
• W132034112 hasPrimaryLocation W1320341121 @default.
• W132034112 hasRelatedWork W1985681015 @default.
• W132034112 hasRelatedWork W2023556803 @default.
• W132034112 hasRelatedWork W2091349841 @default.
• W132034112 hasRelatedWork W2803910286 @default.
• W132034112 hasRelatedWork W2912705052 @default.
• W132034112 hasRelatedWork W2987985474 @default.
• W132034112 hasRelatedWork W3110151069 @default.
• W132034112 hasRelatedWork W3164121017 @default.
• W132034112 hasRelatedWork W3180038703 @default.
• W132034112 hasRelatedWork W4213264857 @default.
• W132034112 hasVolume "118" @default.
• W132034112 isParatext "false" @default.
• W132034112 isRetracted "false" @default.
• W132034112 magId "132034112" @default.
• W132034112 workType "article" @default.